Hem › Akut lymfoblastisk leukemi › Utah
Kliniska studier för Akut lymfoblastisk leukemi i Utah
10 studier för Akut lymfoblastisk leukemi söker deltagare vid platser i Utah.
Städer i Utah
Officiell studietext (engelska)
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Rekryterar
Ålder 1 till 25 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05621291A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Primary Children's Hospital, Salt Lake City
RekryterarFas 1
Ålder 0 till 18 · Alla kön · Uppdaterad 16 sep. 2026 · NCT06173518Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
- Huntsman Cancer Institute, Salt Lake City
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 26 aug. 2026 · NCT06227026The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Primary Children's Hospital, Salt Lake City
RekryterarFas 1/2
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Primary Children's Hospital, Salt Lake City
RekryterarFas 2
Ålder 7 till 25 · Alla kön · Uppdaterad 19 aug. 2026 · NCT05082519A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Utah, Salt Lake City
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- University of Utah Huntsman Cancer Institute, Salt Lake City
RekryterarFas 1/2
Upp till ålder 1 · Alla kön · Uppdaterad 3 juni 2026 · NCT05848687Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- University of Utah, Salt Lake City
RekryterarFas 1
Ålder 13 och äldre · Alla kön · Uppdaterad 5 maj 2026 · NCT04771572A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 24 mars 2026 · NCT04988555Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Primary Children's Hospital, Salt Lake City
RekryterarFas 1
Ålder 1 till 21 · Alla kön · Uppdaterad 6 dec. 2024 · NCT05476770Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.